| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.009 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |